Next Article in Journal
CT Detection of an Anomalous Left Circumflex Coronary Artery from Pulmonary Artery (ALXCAPA) in 81-Year-Old Female Patient
Previous Article in Journal
Molecular Diagnosis of Hypertrophic Cardiomyopathy (HCM): In the Heart of Cardiac Disease
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Nikoloudaki et al. Persistence of Depression and Anxiety despite Short-Term Disease Activity Improvement in Patients with Systemic Lupus Erythematosus: A Single-Centre, Prospective Study. J. Clin. Med. 2022, 11, 4316

by
Myrto Nikoloudaki
1,
Argyro Repa
1,
Sofia Pitsigavdaki
1,
Ainour Molla Ismail Sali
1,
Prodromos Sidiropoulos
1,2,
Christos Lionis
3 and
George Bertsias
1,2,*
1
Department of Rheumatology and Clinical Immunology, University Hospital of Heraklion and Medical School, University of Crete, 71110 Heraklion, Greece
2
Institute of Molecular Biology and Biotechnology—FORTH, 71110 Heraklion, Greece
3
Clinic of Social and Family Medicine, University of Crete Medical School, 71110 Heraklion, Greece
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2023, 12(1), 227; https://doi.org/10.3390/jcm12010227
Submission received: 8 September 2022 / Accepted: 9 November 2022 / Published: 28 December 2022

Text Correction

There was an error in the original publication [1]. In Abstract, “Morisky Medication Adherence Scale-4” has been changed to “a self-reported patient survey”.
A correction has been made to Section 2.3 as follows: “Treatment adherence was estimated with a methodology based on self-reported patient survey (modified from [45])”.
Additionally, in Section 3.4, paragraph 1, a correction has been made as follows: “Using a self-reported measure, we found that 19 out of 40 patients (47.5%) had low or very low adherence to treatment. […] Within patients with low-anxiety levels (HADS-A < 11), the majority (68.4%) had high compliance”.
In Section 3.4, paragraph 2, “This relationship was confirmed by a statistically significant positive correlation between HADS-A and adherence scores treated as continuous variables (Spearman’s rho = 0.324, p = 0.041) (data not shown). Likewise, SLE patients with lower severity of depressive symptoms (HADS-D < 8) had better treatment compliance (58.1% with high compliance) when compared to those with HADS-D ≥ 8 (33.3%)”.
In Section 4, paragraph 5, “the validated MMAS-4 instrument” has been changed to “a self-reported survey”.
Reference correction: remove the ref. 45. With this correction, the order of some references has been adjusted accordingly.

Error in Table

In the original publication, there was a mistake in Table 4. The header “MMAS-4 Score” has been changed to “Treatment adherence (self-reported): highest to lowest”.
The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Nikoloudaki, M.; Repa, A.; Pitsigavdaki, S.; Molla Ismail Sali, A.; Sidiropoulos, P.; Lionis, C.; Bertsias, G.J. Persistence of Depression and Anxiety despite Short-Term Disease Activity Improvement in Patients with Systemic Lupus Erythematosus: A Single-Centre, Prospective Study. J. Clin. Med. 2022, 11, 4316. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Nikoloudaki, M.; Repa, A.; Pitsigavdaki, S.; Sali, A.M.I.; Sidiropoulos, P.; Lionis, C.; Bertsias, G. Correction: Nikoloudaki et al. Persistence of Depression and Anxiety despite Short-Term Disease Activity Improvement in Patients with Systemic Lupus Erythematosus: A Single-Centre, Prospective Study. J. Clin. Med. 2022, 11, 4316. J. Clin. Med. 2023, 12, 227. https://doi.org/10.3390/jcm12010227

AMA Style

Nikoloudaki M, Repa A, Pitsigavdaki S, Sali AMI, Sidiropoulos P, Lionis C, Bertsias G. Correction: Nikoloudaki et al. Persistence of Depression and Anxiety despite Short-Term Disease Activity Improvement in Patients with Systemic Lupus Erythematosus: A Single-Centre, Prospective Study. J. Clin. Med. 2022, 11, 4316. Journal of Clinical Medicine. 2023; 12(1):227. https://doi.org/10.3390/jcm12010227

Chicago/Turabian Style

Nikoloudaki, Myrto, Argyro Repa, Sofia Pitsigavdaki, Ainour Molla Ismail Sali, Prodromos Sidiropoulos, Christos Lionis, and George Bertsias. 2023. "Correction: Nikoloudaki et al. Persistence of Depression and Anxiety despite Short-Term Disease Activity Improvement in Patients with Systemic Lupus Erythematosus: A Single-Centre, Prospective Study. J. Clin. Med. 2022, 11, 4316" Journal of Clinical Medicine 12, no. 1: 227. https://doi.org/10.3390/jcm12010227

APA Style

Nikoloudaki, M., Repa, A., Pitsigavdaki, S., Sali, A. M. I., Sidiropoulos, P., Lionis, C., & Bertsias, G. (2023). Correction: Nikoloudaki et al. Persistence of Depression and Anxiety despite Short-Term Disease Activity Improvement in Patients with Systemic Lupus Erythematosus: A Single-Centre, Prospective Study. J. Clin. Med. 2022, 11, 4316. Journal of Clinical Medicine, 12(1), 227. https://doi.org/10.3390/jcm12010227

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop